Community Health (CG5) AI Stock Analysis

Company Guidance

For full year 2026, net revenue is now expected to be $11.3 billion-$11.5 billion, adjusted EBITDA is expected to be $1.225 billion-$1.275 billion, or a 6.5% reduction at the midpoint, and cash flow from operations is expected to be $100 million-$300 million; fourth-quarter cash flow from operations is expected to be $85 million-$185 million, while capital expenditures are still expected to be between $350 million-$400 million. Year one awards under the Rural Health Transformation Program are expected to be $25 million-$30 million, with income recognized over a multiple year period starting in 2027. The 2027 outlook includes an out-of-period state-directed payment benefit of about a $15 million-$20 million net benefit in 2026 that won't repeat, a modest positive impact from Rural Health Transformation Program funds, another quarter of higher uninsured volumes, a potential moderate headwind in the fourth quarter of 2027 from the OBBBA funding cut to provider taxes, and medical specialties expected to continue to grow well above inflation next year. The full-year 2026 HIX disenrollment and movement to self-pay impact is now expected to be $80 million-$90 million, with the fourth quarter expected to be maybe $25 million-$30 million, and actions taken to date have a future benefit of something in that $100 million range, plus.